THERMO FISHER SCIENTIFIC INC. 4

4 · THERMO FISHER SCIENTIFIC INC. · Filed Mar 14, 2016

Form 4

Period: 2016-03-10

Senior Vice President

Transactions

Exercise/Conversion
Common Stock
2016-03-10$124.28/sh+17,850$2,218,398→ 65,136 total
Exercise/Conversion
Common Stock
2016-03-10$131.07/sh+8,075$1,058,390→ 73,211 total
Sale
Common Stock
2016-03-10$139.56/sh−9,525$1,329,309→ 63,686 total
Sale
Common Stock
2016-03-10$138.75/sh−16,400$2,275,500→ 47,286 total
Exercise/Conversion
Stock Option (Right to Buy)
2016-03-10−17,850→ 17,850 total
Exercise: $124.28Exp: 2021-02-26→ Common Stock (17,850 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2016-03-10−8,075→ 24,225 total
Exercise: $131.07Exp: 2022-02-25→ Common Stock (8,075 underlying)

Holdings

Footnotes (4)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.10 to $140.04, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.18 to $139.09, inclusive.
[F3]The option vests in four equal annual installments beginning on February 26, 2015.
[F4]The option vests in four equal annual installments beginning on February 25, 2016.

Documents

1 file